Skip to main content
OpenTrials
Completed

NCT Number: NCT06014164

Qualitative Study About Psychedelics Using in Psychiatric Disorders

This study is set up to better understand the current use of psychedelics in France in the general population. The present focus on individuals who have used any type of psychedelic drug in order to suppress or alleviate a psychiatric symptom in the context of a diagnosed pathology. The data are collected during a semi-structured interview and then studied in a thematic analysis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psychiatric Disorder Mental Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Toulouse

Toulouse, 31059, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with a psychiatric disorder by a psychiatrist or general practitioner
  • Patients used psychedelic or related substances in order to treat psychiatric symptoms
  • Patients have given their oral non-opposition
  • Patients affiliated to a social security scheme

Exclusion criteria

  • Patients who don't speak or understand French
  • Patients under protection, guardianship or curators

Treatment and study plan

Interview

Diagnostic Test

An interview will be conducted to describe the experiences of people with psychiatric disorders who use psychedelic substances for therapeutic purposes

Primary outcomes

  1. Experiences of people using psychedelic substances

    Time frame: Baseline

    Experiences description of people with psychiatric disorders who use psychedelic substances for therapeutic purposes will be assessed by interview

Secondary outcomes

  1. Profile of people using psychedelic substances

    Time frame: Baseline

    The profile of people with psychiatric disorders who use psychedelic substances for therapeutic purposes will be assessed by interview

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

Qualitative Study of the Self-administered Therapeutic Use of Psychedelics in People With Psychiatric Disorders

Acronym: PSYCHEQUALI

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Aug 28, 2023
Registry last updated
Jul 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.